Neon Therapeutics Overview

  • Founded
  • 2013

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 71

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $67M

  • Investors
  • 4

Neon Therapeutics General Information

Description

Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Primary Office
  • 40 Erie Street
  • Suite 110
  • Cambridge, MA 02139
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-May-2020 $67M 00000 0000 Completed Generating Revenue
3. IPO 27-Jun-2018 00000 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Dec-2017 $106M $161M 00000 Completed Startup
1. Early Stage VC (Series A) 01-Oct-2015 $55M $55M 0000 Completed Startup
To view Neon Therapeutics’s complete valuation and funding history, request access »

Neon Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Neon Therapeutics’s complete cap table history, request access »

Neon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted t
Drug Discovery
Cambridge, MA
71 As of 2019
00000
000 0000-00-00
000000&0 00000

000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ
0000 000000000
Burlingame, CA
00 As of 0000
00000
000000 - 000 00000

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint o
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neon Therapeutics Competitors (61)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corvus Pharmaceuticals Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000 00000000000 Formerly VC-backed Hayward, CA 000 00000 000000000 00000
00 00000000 Formerly VC-backed Glasgow, United Kingdom 00 000.00 000000000 000.00
You’re viewing 5 of 61 competitors. Get the full list »

Neon Therapeutics Board Members (13)

Name Representing Role Since
Cary Pfeffer MD Third Rock Ventures Chairman 000 0000
Robert Kamen Ph.D Third Rock Ventures Board Member 000 0000
Robert Tepper MD Third Rock Ventures Board Member 000 0000
Stephen Sherwin MD Third Rock Ventures Board Member 000 0000
You’re viewing 4 of 13 board members. Get the full list »

Neon Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neon Therapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ArrowMark Partners Asset Manager Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Clal Biotechnology Industries Venture Capital Minority 000 0000 000000 0
Hillhouse Capital Group PE/Buyout Minority 000 0000 000000 0
Nextech Invest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »